1.04956

一水柠檬酸三钾

EMPROVE^® ESSENTIAL, Ph. Eur., BP, USP, FCC, E 332

• 同義詞: tri-Potassium citrate monohydrate, Tripotassium citrate, Citric acid potassium salt, 2-Hydroxy-1,2,3-Propanetriccarboxylic Acid
• 經驗公式（希爾表示法）: C₆H₅K₃O₇ · xH₂O
• CAS號碼: 6100-05-6
• 分子量：: 306.39 (anhydrous basis)
• MDL號碼: MFCD00150442
• 分類程式碼代碼: 12352107
• 酶號碼: E332
• 酶委員會索引編號: 212-755-5

屬性

• agency: BP; Ph. Eur.; USP
• 品質等級: 500
• 法律遵循: FCC
• 產品線: EMPROVE^® ESSENTIAL
• 形狀: solid
• pH值: 7.5-9.0 (20 °C, 50 g/L in H₂O)
• mp: >180 °C (Elimination of water of crystallisation)
• 密度: 1.98 g/cm³ at 20 °C
• 應用: liquid formulation; ophthalmics; pharmaceutical; semi-solid formulation; solid formulation
• 儲存溫度: 15-25°C
• InChI: 1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3
• InChI 密鑰: PJAHUDTUZRZBKM-UHFFFAOYSA-K

描述

一般說明

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge in formulation. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

tri-Potassium citrate is typically used as buffering, alkalizing and sequestering agent. Additional uses include the application as potassium source and as therapeutic ingredient to treat cystitis by alkalizing the urine.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable